Academia
Industry
Remiges Ventures is a US-Japan
cross-border venture capital
firm focused on therapeutics
Technology
Clinical
InnovationRemiges Ventures is a US-Japan
cross-border venture capital
firm focused on therapeutics
Pharma
Biotech
Remiges Ventures is a US-Japan
cross-border venture capital
firm focused on therapeutics
Academia
Industry
Remiges Ventures is a US-Japan
cross-border venture capital
firm focused on therapeutics
Technology
Clinical
InnovationRemiges Ventures is a US-Japan
cross-border venture capital
firm focused on therapeutics
Pharma
Biotech
Remiges Ventures is a US-Japan
cross-border venture capital
firm focused on therapeutics
- 2022.01.10REMIGES NEWS
Inflectis Bioscience receives approval from French regulatory authority to conduct a Phase 2 Clinical Trial for IFB-088 for ALS
- 2021.06.23REMIGES NEWS
Remiges joined Series B Round of Glycomine in California
- 2021.05.27REMIGES NEWS
The core technology of Imel BioTherapeutics, Inc. was published in Scientific Reports
- 2021.04.09REMIGES NEWS
Remiges Ventures Closes Second Fund with $95 million; Launches RDiscovery Incubator
- 2020.12.10REMIGES NEWS
Remiges led the Series A round of finance for Cyrano Therapeutics in Washington D.C.
- 2020.07.09REMIGES NEWS
Remiges co-led the Series A round of finance for Tranquis Therapeutics in California
